Similar to the regulation of claudins, the up-regulation of core transcription factors in claudin-low breast cancers was at the transcriptional or post-transcriptional level, as only a small percentage of cases displayed amplifications in the respective genes, which in fact was higher in basal ER-negative/HER2-negative cancers (Figure 3). The gene discussed is ERBB2; the disease is breast carcinoma.